Abstract:In the mesopic range, mild hypoxia impairs chromatic sensitivity progressively with reducing luminance. Binocular summation of chromatic signals is consistent and independent of the luminance channel. The CAD test is highly sensitive to mild congenital and acquired color vision deficiencies.
“…As pointed out recently [45], it is important to have sensitive and objective criteria that experts can use to decide whether small changes in vision in older subjects can be attributed entirely to normal aging or reflect early signs of retinal pathology. Since visual performance at lower light levels is more compromised in patients with early signs of ocular pathology [4] and the effects of mild acute hypoxia in normal subjects are also more detectable at lower light levels [5,6,46,47], it may be desirable to assess changes in visual performance over a range of light levels and not just photopic vision under optimum conditions. Indeed, if the HR index does reflect retinal susceptibility to disease, and hence hypoxia, imposed mild systemic hypoxia may exacerbate the loss of chromatic sensitivity as reflected in the HR index , more so in older subjects and/or those with more severe damage to the retina.…”
Section: Discussionmentioning
confidence: 99%
“…Vision at low light levels is also compromised by imposed mild levels of hypoxia in healthy young subjects [5,6]. Other studies have shown that healthy normal observers who are carriers of the CFH, LOC387715, and HRTA1 genotypes and are considered to be of high risk of developing age-related maculopathy later in life perform significantly worse in the mesopic range in some visual tasks, but not at higher light levels [7].…”
This is the unspecified version of the paper.This version of the publication may differ from the final published version. The purpose of this study was to obtain additional information about the health of the retina (HR) by measuring the rate of loss of chromatic sensitivity with decreasing light level. The HR index is introduced to separate the effects of normal aging from early stage disease. For normal subjects the HR index is largely independent of age (r 2 ∼ 0.1), but ∼11% of clinically normal, asymptomatic, older subjects exhibit values below the 2σ limit. The HR index provides a single number that captures how light level affects chromatic sensitivity irrespective of age and can be used to screen for preclinical signs of retinal disease.
Permanent
“…As pointed out recently [45], it is important to have sensitive and objective criteria that experts can use to decide whether small changes in vision in older subjects can be attributed entirely to normal aging or reflect early signs of retinal pathology. Since visual performance at lower light levels is more compromised in patients with early signs of ocular pathology [4] and the effects of mild acute hypoxia in normal subjects are also more detectable at lower light levels [5,6,46,47], it may be desirable to assess changes in visual performance over a range of light levels and not just photopic vision under optimum conditions. Indeed, if the HR index does reflect retinal susceptibility to disease, and hence hypoxia, imposed mild systemic hypoxia may exacerbate the loss of chromatic sensitivity as reflected in the HR index , more so in older subjects and/or those with more severe damage to the retina.…”
Section: Discussionmentioning
confidence: 99%
“…Vision at low light levels is also compromised by imposed mild levels of hypoxia in healthy young subjects [5,6]. Other studies have shown that healthy normal observers who are carriers of the CFH, LOC387715, and HRTA1 genotypes and are considered to be of high risk of developing age-related maculopathy later in life perform significantly worse in the mesopic range in some visual tasks, but not at higher light levels [7].…”
This is the unspecified version of the paper.This version of the publication may differ from the final published version. The purpose of this study was to obtain additional information about the health of the retina (HR) by measuring the rate of loss of chromatic sensitivity with decreasing light level. The HR index is introduced to separate the effects of normal aging from early stage disease. For normal subjects the HR index is largely independent of age (r 2 ∼ 0.1), but ∼11% of clinically normal, asymptomatic, older subjects exhibit values below the 2σ limit. The HR index provides a single number that captures how light level affects chromatic sensitivity irrespective of age and can be used to screen for preclinical signs of retinal disease.
Permanent
“…Although there is a fair degree of individual variability, losses in color discrimination are primarily along the tritan axis and begin to occur at oxygen concentrations that are equivalent to an altitude of 2400 m (∼8; 000 ft) at mesopic light levels. The discrimination losses begin to occur at photopic light levels as the altitude increases beyond 3000 m (∼9; 000 ft), with more marked losses occurring above 4000 m (∼13; 100 ft) [1][2][3][4][5][6][7][8][9][10]. In addition to the color discrimination losses along the tritan axis at higher altitudes, the Nagel anomaloscope settings tend to require more green to match yellow, and there may be a relative decrease in the sensitivity to green light when measured using heterochromatic flicker photometry, especially at conditions equivalent to altitudes above 4000 m [2][3][4][5][6]11].…”
Section: Introductionmentioning
confidence: 99%
“…With the exception of two studies [9,11], subjects participating in these hypoxia experiments all had normal color vision (NCV). In one of these studies, Schmidt reported that hypoxia produced subtle effects on the red-green color matches made by NCV and individuals with congenital anomalous trichromatic red-green defects (DCV) using the anomaloscope [11].…”
Chromatic thresholds were measured using the Cambridge Colour Test (CCT), the Colour Assessment and Diagnosis (CAD) test, and the Cone Specific Contrast Test (CSCT) at ground and 3780 m (12,400 ft) for subjects with normal color vision and red-green color vision defects. The CAD revealed a small (~10%) increase in the red-green thresholds for the trichromatic subjects and a similar increase in the blue-yellow thresholds for the dichromats. The other two color vision tests did not reveal any significant change in chromatic thresholds. The CAD results for the trichromats were consistent with a rotation of the discrimination ellipse counterclockwise with little change in the elliptical area. This alteration in the color discrimination ellipse can occur when retinal illumination is lowered.
“…A four-alternative, forced-choice procedure is employed to measure the subject's thresholds for detection of colour signals in 16 directions in colour space, while ensuring that the subject cannot make use of any residual luminance contrast signals. 13 The Nidek Microperimeter (Nidek Technologies, Padova, Italy) was used to quantify macular sensitivity and fixation. It incorporates an eye tracker to compensate for eye movements and allows automated follow-up examination at the same retinal loci and also allows colour fundus image registration by infra-red camera (451 field of view).…”
Purpose To evaluate the morphological and functional changes following intravitreal Ozurdex (dexamethasone implant) injections in patients with macular oedema (MO) secondary to retinal vascular diseases. Design This is a single centre, exploratory phase III, prospective, open-label clinical study. Methods Thirty patients with MO secondary to retinal vascular disorders underwent assessments for best corrected visual acuity, contrast sensitivity, microperimetry, chromatic sensitivity, macular thickness, and morphology using spectral domain optical coherence tomography (SD-OCT) and fluorescein angiography at baseline. They were treated with intravitreal Ozurdex at baseline and monitored monthly with visual acuity and SD-OCT assessments up to 36 weeks. Re-treatment was permitted from 16 to 24 weeks according to pre-defined criteria. All visual function tests were repeated at 24 weeks. Results The mean change in central subfield thickness (CST) from baseline was significant at all visits up to 32 weeks. The lowest mean CST was recorded at 8 weeks and the highest mean ETDRS score was achieved at 12 weeks. All visual functions except contrast sensitivity improved significantly by 24 weeks. The study showed that the ideal re-treatment time point based on functional and structural outcomes and known side-effects of Ozurdex treatment is at 20 weeks. Conclusion Ozurdex therapy has a rapid and dramatic effect on the macula for about 8 weeks followed by a sustained modest effect up to week 32. The optimal re-treatment time point is at 20 weeks.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.